• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML; SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML; SYSTEM, BLOOD CULTURING Back to Search Results
Catalog Number 245122
Device Problems Device Markings/Labelling Problem (2911); Device Contamination with Chemical or Other Material (2944)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/11/2023
Event Type  malfunction  
Manufacturer Narrative
Initial reporter address: metro manila don euqenio sr.Medical complex,ortigas ave, h.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that one bd bbl¿ mgit¿ mycobacteria growth indicator tubes, 7ml is contaminated and had no label.No patient impact was reported.The following information was provided by the initial reporter: 1 mgit tube is contaminated and another one has no sticker label.
 
Event Description
It was reported that one bd bbl¿ mgit¿ mycobacteria growth indicator tubes, 7ml is contaminated and had no label.No patient impact was reported.The following information was provided by the initial reporter: 1 mgit tube is contaminated and another one has no sticker label.
 
Manufacturer Narrative
H.6.Investigation summary: material 245122 is manufactured by rehydrating the media components with usp purified water, and thoroughly mixing until a homogeneous solution is obtained.The tubes are filled, capped, torqued, and then labeled by machine per standard operating procedure (sop).The tubes are terminally autoclaved in an air over pressure (aop) autoclave, per manufacturing instructions, using a validated cycle.Post autoclaving, tubes are packaged into final shipping configurations.The batch history record review for batch 2188093 was satisfactory per internal procedures.Formulation, filling, torquing, labeling, and autoclaving processes were within specifications.Qc inspection and testing were satisfactory at time of release.As part of the release criteria for this product, the bhr is reviewed to confirm the following: the total elapsed time between end of formulation and start of the autoclave cycle was within the specified limits.All autoclave parameters conformed to the validated cycle parameters for this product.The minimum f0 for this product was met.The complaint history was reviewed, and two other complaints have been taken on this batch for contamination, and one other complaint has been taken on this batch for labeling.Retention samples from batch 2188093 (100 tubes) were available for inspection.All 100/100 retention samples had properly affixed, legible labels and scannable barcode labels.The retention samples showed no signs of turbidity or contamination in 100/100 retention tubes.For further investigation 10 retention tubes were incubated.Five tubes were placed into 33-37-degrees celsius incubation, and five tubes were placed into 20-25-degrees celsius incubation.At the end of a seven-day incubation period no microbial growth was observed in 10/10 incubated retention tubes.One photo was received to assist with the investigation: the photo shows two tubes from batch 2188093.The tube on the left appears to be contaminated possibly fungal growth.The tube on the right is missing a label.No returns were received to assist with the investigation.This complaint can be confirmed based on the evidence provided by the photo received.No complaint trends for this defect have been identified for this product; no actions are indicated at this time.H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jennifer suh
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17621134
MDR Text Key321924176
Report Number1119779-2023-00941
Device Sequence Number1
Product Code MDB
UDI-Device Identifier30382902451229
UDI-Public30382902451229
Combination Product (y/n)N
Reporter Country CodeRP
PMA/PMN Number
K974883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date12/31/2023
Device Catalogue Number245122
Device Lot Number2188093
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/11/2023
Initial Date FDA Received08/25/2023
Supplement Dates Manufacturer Received10/14/2023
Supplement Dates FDA Received10/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-